Copyright: ©Author(s) 2026.
World J Gastroenterol. Jun 28, 2026; 32(24): 118709
Published online Jun 28, 2026. doi: 10.3748/wjg.118709
Published online Jun 28, 2026. doi: 10.3748/wjg.118709
Table 3 Adjustment models
| Model 1 | Model 2 | Model 3 | |||||||
| OR | 95%CI | P value | OR | 95%CI | P value | OR | 95%CI | P value | |
| HBV DNA (< 20) (IU/mL) | Reference | Reference | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
| HBV DNA (20-2000) (IU/mL) | 2.566 | 1.236-5.328 | 0.011 | 2.669 | 1.274-5.709 | 0.010 | 2.879 | 1.331-6.376 | 0.008 |
| HBV DNA (> 2000) (IU/mL) | 2.982 | 1.288-6.909 | 0.011 | 2.987 | 1.278-7.097 | 0.012 | 3.610 | 1.438-9.325 | 0.007 |
| TACE | 2.245 | 1.188-4.244 | 0.013 | 2.180 | 1.137-4.221 | 0.019 | 2.321 | 1.170-4.663 | 0.017 |
| Child-Pugh stage | 0.409 | 0.191-0.875 | 0.021 | 0.404 | 0.180-0.851 | 0.021 | 0.352 | 0.121-0.943 | 0.044 |
- Citation: Jie XH, Xi DY, Zhang SS, Yan XB. Acute liver injury after transcatheter arterial chemoembolization in patients with hepatitis B virus-related intermediate or advanced hepatocellular carcinoma stages. World J Gastroenterol 2026; 32(24): 118709
- URL: https://www.wjgnet.com/1007-9327/full/v32/i24/118709.htm
- DOI: https://dx.doi.org/10.3748/wjg.118709